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In the adult nervous system, neurotransmitters mediate cellular communication within neuronal
circuits. In developing tissues and primitive organisms, neurotransmitters subserve growth
regulatory and morphogenetic functions. Accumulated evidence suggests that acetylcholine,
(ACh), released from growing axons, regulates growth, differentiation, and plasticity of
developing central nervous system neurons. In addition to intrinsic cholinergic neurons, the
cerebral cortex and hippocampus receive extensive innervation from cholinergic neurons in the
basal forebrain, beginning prenatally and continuing throughout the period of active growth and
synaptogenesis. Acute exposure to ethanol in early gestation (which prevents formation of basal
forebrain cholinergic neurons) or neonatal lesioning of basal forebrain cholinergic neurons,
significantly compromises cortical development and produces persistent impairment of cognitive
functions. Neonatal visual deprivation alters developmental expression of muscarinic
acetylcholine receptors (mAChR) in visual cortex, whereas local infusion of mAChR antagonists
impairs plasticity of visual cortical neurons. These findings raise the possibility that exposure to
environmental neurotoxins that affect cholinergic systems may seriously compromise brain
development and have long-lasting morphologic, neurochemical, and functional consequences.
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Classical neurotransmitters, such as
acetylcholine (ACh), dopamine (DA), nora-
drenaline (NA), adrenaline (A), serotonin
(5-HT), and y-aminobutyric acid (GABA),
act as developmental signals in all animal
species studied. These substances play regu-
latory roles throughout ontogenesis, includ-
ing stages prior to development of the
nervous system [see reviews by Buznikov et
al. (1) and Lauder (2-4)].
Morphogens are developmental signals
that exert specific effects on receptive cells,
depending on concentration. Morphogens
are present in gradients created by the pres-
ence ofa "source" and a "sink." Developing
cells are affected in specific ways along this
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concentration gradient [reviewed by Lauder
(2)]. This concept has traditionally been
applied to substances involved in pattern for-
mation and morphogenesis, such as retinoic
acid. However, it may also be appropriate to
consider neurotransmitters as morphogens
when they act as dose-dependent morpho-
genetic signals in neural and nonneural tis-
sues. Neurotransmitters have these types of
actions in primitive organisms and embryos,
where they exert their effects using receptors
and signal transduction mechanisms similar
to those in the adult nervous system (1-3).
This raises the possibility that the highly spe-
cialized roles played by neurotransmitters in
synaptic transmission may have evolved
from phylogenetically old functions, many
ofwhich are recapitulated during develop-
ment. This may make developing neuro-
transmitter systems especially vulnerable to
environmental neurotoxins, such as pesti-
cides, designed to target receptors for these
neurochemicals in lowerorganisms.
Developmental Roles
ofAcetylcholine
Acetylcholine is a major excitatory neuro-
transmitter in the nervous system ofverte-
brates and invertebrates. Accumulated
evidence suggests that ACh also plays a key
role in regulation of morphogenetic cell
movements, cell proliferation, growth, and
differentiation in species as diverse as
echinoderms, insects, worms, avians,
rodents, and humans.
CholinergicRegulationof
Morphogenetic Celi Movements
inEarlyEmbryos
In sea urchin embryos, cell movements
occurring during gastrulation and postgas-
trulation stages appear to be regulated by
ACh and biogenic monoamines (5-10).
Specific antagonists of receptors for these
neurotransmitters act as inhibitors of mor-
phogenetic cell movements during specific
phases ofgastrulation. For example, 5-HT
receptor antagonists are effective in block-
ing cell movements throughout this period,
whereas ACh antagonists act only during
the final phases ofgastrulation (5), and do
not affect cleavage divisions (8,9). The
ability of both 5-HT and ACh to affect
gastrulating sea urchin embryos suggests
that receptors for these neurotransmitters
are expressed at the time ofgastrulation by
cells of the primary gut and mesenchyme
(5,6). Histochemical evidence has demon-
strated the presence ofacetylcholinesterase
(AChE) during sea urchin gastrulation
where it is localized predominantly in the
primary gut, which is the site of the most
active cell movements (7,10).
Similar functions ofACh during gastru-
lation ofvertebrate embryos are suggested
by the presence ofAChE during gastrula-
tion in the chick embryo (11,12). Other
morphogenetic roles for ACh during verte-
brate embryogenesis are suggested by the
early presence of choline acetyltransferase
(ChAT), cholinesterases, and muscarinic
cholinergic receptors (mAChR) in mes-
enchyme and developing cartilage of the
chick limbud (13,14) and myotomes (15).
In the mouse embryo, ACh may also play a
role in palate morphogenesis as suggested
by the ability of cholinergic receptor
agonists to stimulate elevation ofpalatal
shelves-effects that are blocked by
nicotinic cholinergic receptor (nAChR)
antagonists, but not by mAChR receptor
antagonists (16).
Cholinergc Regulation
ofCeliProlieraton
Neurotransmitters stimulate or inhibit
proliferation of nonneuronal cells by
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activating receptors coupled to different
G-proteins and second messenger path-
ways [reviewed by Lauder (3) and Weiss
et al. (17)]. Stimulation ofproliferation is
most often associated with activation of
G-proteins negatively coupled to adenylyl
cyclase (G1), or positively coupled to
other pertussis toxin-sensitive G-proteins
(G.) or phospholipase C-5 (PLC) Gq-
coupled pathways. In contrast, activation
of neurotransmitter receptors positively
coupled to cAMP usually inhibits cell
proliferation and causes cell shape changes
indicative ofdifferentiation.
Neurotransmitters that promote cell
proliferation include 5-HT, adenosine
(A), noradrenaline (NA), and ACh.
Stimulation ofmAChR by carbachol pro-
motes DNA synthesis in cultured astro-
cytes and in fibroblasts transfected with
genes coding for ml, m3, and m5 sub-
units ofthe human mAChR. These mito-
genic responses are correlated with
increased activity ofPLC (18-20). Recent
evidence suggests that activation of Gq-
coupled M1, M3, and M5 mAChR recep-
tor subtypes stimulates mitogen-activated
protein kinase by PLC-dependent and
PLC-independent mechanisms (21), and
that mAChR activate the Egr family of
transcription factors (22). These findings
may shed light on mechanisms underlying
mitogenic effects of mAChR activation.
Muscarinic receptor-dependent activation
of PLC has also been reported in human
fetal brain slices (23), suggesting that
similar mechanisms may be important for
development of the human nervous
system. Growth-promoting actions of
endogenous ACh are suggested by the
severe growth defects observed in ChAT-
deficient nematode and Drosophila
mutants (24).
Activation of Gq-coupled M1, M3,
and M5 mAChRs can also stimulate
adenylyl cyclase and inhibit cell prolifera-
tion in a number of cell types. These
effects occur by mechanisms independent
of PLC-mediated phosphoinositide (PI)
hydrolysis, possibly involving liberation of
^y subunits from Gq (25). Such mecha-
nisms may underlie the inhibitory effects
ofcarbachol on proliferation offibroblasts
transfected with gene sequences encoding
Ml, M3, and M5 mAChRs (19,26).
Inhibitory effects ofacetylcholine on stem
cell proliferation are indicated by the pos-
itive effects of antisense oligonucleotides
for AChE on proliferation and expansion
of progenitor cells in bone marrow
cultures (27).
Cholinergic Rulation ofCeli
Survival and Neurite Outgowh
Acetylcholine has been shown to regulate
neurite outgrowth in both snail (Helisoma)
and mammalian neurons [reviewed by
Lipton and Kater (28)]. When ACh is
directly applied to cultured Helisoma
neurons, it inhibits neurite outgrowth, but
when added together with 5-HT, it prevents
inhibition of neurite outgrowth by 5-HT
(29). Acetylcholine may be a negative influ-
ence on neurite outgrowth in mammalian
neurons, as nicotinic antagonists enhance
process outgrowth in cultured rat retinal
ganglion cells, presumably by blocking the
inhibitory effects ofACh released from
amacrine neurons into the culture medium
(30). Acetylcholine has also been reported to
inhibit neurite outgrowth in rat hippocam-
pus (31). However, activation ofnAChRs
has been reported to promote survival of
chicken spinal motoneurons that would
otherwise undergo programmed cell death
when deprived oftrophic factors (32). In
addition, significant direct roles for AChEs
in neurite outgrowth have recently been
reported, as discussed by Brimijohn and
Koenigsberger (33) and Bigbee etal. (34).
Development ofthe Central
Cholinergic Nervous System
Central cholinergic neurons detected by
ChAT immunoreactivity are concentrated
in the mediobasal forebrain, and brainstem
(35), but are also present throughout the
cerebral cortex (36) and hippocampus (37).
Mediobasal cholinergic forebrain neurons
project to cortex and hippocampus (38),
where nAChRs and mAChRs are expressed
in both neonatal and adult rat brain
(39-41).Most neurons expressing these
receptors also contain AChE (42). Cloning
ofthe nAChRand in situhybridization have
revealed multiple subunits that are differen-
tially expressed throughout the brain.
Several of these subunits are highly
expressed in cortex, hippocampus, and the
septal area (39,43,44).
Preata Ontogeny of
Cholinergic Neuronis
Ontogeny ofcholinergic neurons in the
brain and spinal cord of mouse and rat
embryos has been studied in detail using
ChAT immunocytochemistry to study
prenatal development of the cholinergic
phenotype (45,46) and ChAT immuno-
cytochemistry combined with long survival
[3H]thymidine autoradiography to date the
time oforigin (day oflast cell division of
progenitors) of cholinergic neurons
[reviewed by Semba (47)]. From these
studies, a detailed picture of prenatal
ontogeny of the cholinergic system has
been revealed.
In the rat embryo, cholinergic neurons
are generated earliest in the spinal cord and
brainstem, beginning at embryonic day
(E)11, and continue to be generated in
these regions through E14, with peak gen-
eration at E12 to E13 (47). Cholinergic
neurons in most other brain regions are
generated between E12 to E16, with the
exception of the basal ganglia, where
cholinergic neurons begin to be generated
on El1. Most studies in the rat embryo
suggest that the cholinergic phenotype
(ChAT immunoreactivity) appears 1 to 2
days following generation ofneurons from
dividing progenitor cells. However, this
view differs from evidence for the sequence
ofcholinergic phenotype development in
the mouse embryo, as discussed below.
In the mouse embryo, Schambra et al.
(45) demonstrated that cholinergic neurons
ofthe forebrain are generated from distinct
germinal zones in the olfactory, lateral, and
third ventricles between E14 to E16. In this
study, ChAT immunoreactivity revealed
mitotic figures in these germinal zones, sug-
gesting that progenitor cells already
expressed a cholinergic phenotype prior to
the time oflast cell division and onset of
neuronal differentiation. Because ofthis
early expression, ChAT immunoreactive
cells could be followed along their migra-
tory routes to final destinations in specific
brain structures. From this analysis, germi-
nal zones giving rise to specific populations
of cholinergic neurons could be deter-
mined. For example, cholinergic neurons of
the basal ganglia were found to originate
from germinal zones located in the ventric-
ular epithelium ofthe ganglionic eminence,
adjacent to the lateral ventricle, whereas
intrinsic cholinergic neurons ofthe cerebral
cortex and hippocampus, as well as projec-
tion neurons in the mediobasal forebrain,
were derived from other germinal zones of
the lateral ventricles. Cholinergic neurons
ofthe hypothalamic preoptic nucleus and
habenula were derived from germinal zones
of the third ventricle. By late gestation
(E16-E18) cholinergic neurons could be
seen migrating within the cortical plate,
which gives rise to the six layers ofthe neo-
cortex. Other cholinergic neurons were
found in the CA2 region ofthe hippocam-
pus, where they were located in a position
to form transient targets ofgranule cell
mossy fibers, which do not cross this region
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into the more distal hippocampal CAl
region. Further migration of cholinergic
neurons into the basal ganglia and cerebral
cortex was observed just following birth.
Prenatal OntogenyofMuscarinic
andNicotinic Recptors
Both mAChR and nAChR cholinergic
receptors have been detected by radioli-
gand autoradiography in the prenatal rat
brain, where they appear to develop in a
caudal-rostral gradient (48,49). However,
nAChRs appear to be expressed earlier
than mAChRs, where they can be detected
in spinal cord and brainstem by E12.
These receptors appear in more rostral
brain regions (mesencephalon, dien-
cephalon) by E14 and can be detected in
deep layers of neocortex by E18 (48). In
the human fetus, nAChRs are highly
expressed in the brainstem at midgestation,
followed by a decline to low levels prior to
birth (50).
Muscarinic receptors are not detectable
in rat brainstem and spinal cord until E16
and do not reach maximal levels until the
end ofgestation. Expression ofthese recep-
tors in more rostral brain regions occurs
after E16 and only begins to reach maximal
levels just before birth (49). In cerebral cor-
tex, mAChR appear to surround the corti-
cal plate at El8, during the period ofactive
migration ofcholinergic neurons through
this cortical region (45), and by E22 are
found throughout the developing neocortex
(49). Accumulating evidence indicates that
expression ofnAChR may be regulated by
signals intrinsic (51) and extrinsic to their
cortical location (52,53). Postnatally, many
ofthese influences may come from cortical
cholinergic and noncholinergic afferents, as
discussed below.
Acetylcholine andCorticalPlasticity
Although intrinsic cholinergic neurons are
born and migrate to the cerebral cortex
prenatally, innervation of the cortex by
cholinergic afferents (primarily from the
mediobasal forebrain nucleus basalis mag-
nocellularis, nBM) does not begin until
after birth and is only completed by about
2 months postnatally in rodents. This coin-
cides with the period ofmost active cortical
development and synaptogenesis [reviewed
by Bachman et al. (54) and Hohmann and
Berger-Sweeney (55)].
Neonatal Lesions of Forebrain
CholinergicNeurons. Convincing evidence
for a developmental role ofACh in post-
natal cortical development comes from the
work ofHohmann and colleagues (54-58)
who have shown that neonatal lesions of
mouse of nBM cholinergic neurons pro-
duce abnormal cortical development,
including aberrant lamination, dendritic
growth, and positioning ofpyramidal cells,
as well as altered cortical connectivity.
These changes lead to cognitive deficits in
adult animals. A recent report that growth
and differentiation of cortical neurons is
stimulated in co-cultures with nBM cholin-
ergic neurons (59) provides further support
for the view that forebrain cholinergic neu-
rons are important for normal development
ofthe cerebral cortex.
Many of the effects of neonatal lesion-
ing ofmouse forebrain cholinergic neurons
appear to be mediated by mAChRs
(55,60-62), in particular, the Ml, M2, and
M4 subtypes, which exhibit different pat-
terns ofexpression in developing cortex. The
Ml and M4 subtypes exhibit interesting
transient expression patterns in fiber tracts,
the cerebral pedundes, and barrel fields, sug-
gesting that they may be involved in axonal
growth and cellular rearrangements during
barrel field morphogenesis.
Rett Syndrome. Rett syndrome is a
developmental disorder that presents in
early childhood following a relatively
normal infancy. This syndrome is character-
ized by deceleration of head growth and
acquired microcephaly, reduced neuropil
development in the cerebral cortex and hip-
pocampus, and decreased numbers ofbasal
forebrain cholinergic neurons. These chil-
dren exhibit behavioral regression, stereo-
typed hand movements, seizures, breathing
abnormalities, and severe mental retarda-
tion. This syndrome shares manysimilarities
with the effects ofbasal forebrain lesions in
neonatal mice. As such, it provides further
evidence for the importance of acetyl-
choline in postnatal brain development and
consequent behavior (63).
AcetylcholineandOcularDomi2nance
During development of the kitten visual
cortex, synaptic competition between thala-
mocortical afferents driven by each eye leads
to synaptic rearrangements that are critical
for the formation of ocular dominance
columns. Deprivation ofinput from one eye
during a critical period ofcortical develop-
ment interferes with these synaptic
rearrangements and leads to inability ofthe
affected eye to drive visual cortical cells even
after vision has been restored (64,65).
Ocular dominance plasticity can be blocked
by combined lesions of cholinergic and
noradrenergic cortical afferents (66). This
effect can be mimicked by infusion ofMl
mAChR antagonists (67), suggesting that
these receptors are involved in mediating the
effects ofcholinergic afferents on visual cor-
tical plasticity. Monocular deprivation
causes transient changes in developmental
regulation ofM2, M3, and M4 but not Ml
mAChR mRNAexpression in ratvisual cor-
tex (68,69), although with receptor autora-
diography, effects on M1 receptors were
found (70). The latter finding is supported
by studies in kitten visual cortex, where M1
mAChRs also appear to be affected by
monocular deprivation (71). Together, all
ofthese studies suggest that neonatal visual
cortical plasticity involves activation of
mAChRs. In the chick optic tectum, how-
ever, nAChRs may also play a role in wiring
ofvisual pathways. In this species, na (non-
alpha) subunits of the nAChR are tran-
siently expressed in the optic tectum during
innervation by optic nerve fibers, whereas in
"eyeless" embryos in which both optic vesi-
cles have been removed, this transeint
expression does not occur (72). This sug-
gests that nAChR may be involved in devel-
opment ofthe retinotectal projection in the
chickembryo.
Effects of Cholinergic
Disruptors on Neural
Development
Evidence that acetylcholine plays key roles
in neural development suggests that disrup-
tors ofcholinergic function could disturb
these actions ifpresent during key critical
periods. The cerebral cortex may be
especially vulnerable to such insults because
ofthe important roles cholinergic afferents
play in cerebral morphogenesis and synap-
togenesis. Disruptors ofcholinergic func-
tion that may have significant effects on
brain development include alcohol, nico-
tine, and cholinergic pesticides. Effects of
nicotine and cholinergic pesticides are
covered in the review by Slotkin (73).
FealAlcoholSyndrome
Abuse of alcohol in pregnancy has been
linked to mental retardation and develop-
mental delays, growth deficiencies, and
craniofacial abnormalities in children
(fetal alcohol syndrome [FAS]). In an ani-
mal model ofFAS (74), administration of
two doses of ethanol (500-600 mg/dl
final blood concentration) to pregnant
mice on E7 caused similar craniofacial
defects in mouse embryos and severely
affected development of the forebrain
CNS cholinergic system. As might be
expected from the effects of neonatal
lesions of forebrain cholinergic neurons
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discussed above, deleterious effects on
synaptic targets of these cholinergic
neurons were also observed, including
reduced thickness of the cerebral cortex
and decreased size ofthe basal ganglia.
Summary and Conclusions
Prenatal development ofthe central cholin-
ergic nervous system coupled with the
important developmental roles played by
acetylcholine in both neural and nonneural
tissues should make the vertebrate embryo
especially vulnerable to the gestational
effects of environmental neurotoxins that
target cholinergic receptors or choline
esterases. It seems especially important to
study the effects of chronic prenatal expo-
sure to cholinergic pesticides on pre- and
postnatal brain development as well as
behavioral consequences ofthese exposures.
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